Drugplain

Budesonide .25 mg/2mL

Budesonide · SUSPENSION · Teva Pharmaceuticals USA, Inc.

10 Recalls on Record
Plain English

Budesonide is a suspension containing budesonide at .25 mg/2mL, taken respiratory (inhalation). Manufactured by Teva Pharmaceuticals USA, Inc..

Key Facts

Brand Name
Budesonide
Generic Name
Budesonide
NDC Code (Product)
0093-6815
Manufacturer
Teva Pharmaceuticals USA, Inc.
Strength
.25 mg/2mL
Dosage Form
SUSPENSION
Route
RESPIRATORY (INHALATION)
Marketing Status
Application #
ANDA077519
Drug Class
Corticosteroid [EPC]
Marketing Start
01/11/2019

Recall History

10 Recalls on Record
Class II05/21/2012

Franck's Lab Inc., d.b.a. Franck's Compounding Lab

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

TerminatedVoluntary: Firm initiated
Class II01/12/2024

Golden State Medical Supply Inc.

Failed Dissolution Specifications

TerminatedVoluntary: Firm initiated
Class II01/08/2024

Teva Pharmaceuticals USA, Inc

Failed Dissolution Specifications

OngoingVoluntary: Firm initiated
Class II05/14/2025

AsttraZeneca Pharmaceuticals LP

Defective delivery system

OngoingVoluntary: Firm initiated
Class II06/30/2025

Cipla USA, Inc.

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

OngoingVoluntary: Firm initiated
Class II11/14/2014

Attix Pharmaceuticals

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

TerminatedVoluntary: Firm initiated
Class II11/12/2019

Integrated Health Concepts Inc. dba Conversio Health

Lack of Processing Controls

TerminatedVoluntary: Firm initiated
Class II11/12/2019

Integrated Health Concepts Inc. dba Conversio Health

Lack of Processing Controls

TerminatedVoluntary: Firm initiated
Class II06/22/2015

Solutions Rx Pharmacy

Penicillin Cross Contamination - Possible presence of penicillin in bulk budesonide powder used to compound prescription nasal rinse/nebulizer capsules.

TerminatedVoluntary: Firm initiated
Class II03/25/2016

Reliable Rexall-A Compounding Pharmacy

Lack of Processing Controls

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective4,703 reports
dyspnoea4,406 reports
off label use4,252 reports
asthma3,524 reports
fatigue2,472 reports
condition aggravated2,379 reports
headache2,328 reports
diarrhoea2,242 reports
cough2,138 reports
pneumonia2,129 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Use s Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • runny nose • itchy nose • sneezing

Dosage & Administration

Directions Read insert (inside package) on how to: get a new bottle ready (primed) before first use prime bottle again if not used for two days use the spray clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per day CHILDREN 6 TO UNDER 12 YEARS OF AGE the growth rate of some children may be slower while using this product. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year children 6 to under 12 years of age an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day children under 6 years of age do not use do not use more than directed if you forget a dose, do not double the next dose do not spray into eyes or mouth if allergy symptoms do not improve after two weeks, stop using and talk to a doctor do not use for the common cold shake well before eac

Warnings

Warnings Do not use in children under 6 years of age if you have ever had an allergic reaction to any of the ingredients Ask a doctor before use if you have had recent nose ulcers or nose surgery have had a nose injury that has not healed are using a steroid medicine for asthma, allergies or skin rash have an eye infection have or had glaucoma or cataracts When using this product the growth rate of some children may be slower some symptoms may get better on the first day of treatment. It may take up to two weeks of daily use to feel the most symptom relief. do not share this bottle with anyone else as this may spread germs remember to tell your doctor about all the medicines you take, including this one Stop use and ask a doctor if you have, or come into contact with someone who has, chickenpox, measles or tuberculosis you have or develop symptoms of an infection such as persistent fever you have any change in vision you have severe or frequent nosebleeds If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Frequently Asked Questions

What is Budesonide used for?

Budesonide contains Budesonide. It is a suspension taken respiratory (inhalation). Consult your doctor for specific uses.

Is Budesonide a controlled substance?

Budesonide is not classified as a controlled substance by the DEA.

What is the generic name for Budesonide?

The generic name for Budesonide is Budesonide. There are 9 other brand versions of Budesonide.

What is the NDC code for Budesonide .25 mg/2mL?

The NDC (National Drug Code) for Budesonide .25 mg/2mL is 0093-6815, listed by Teva Pharmaceuticals USA, Inc..